Sopan Pharmaceuticals Shares Registered at CDSC, Trading Expected to Begin Soon
Sopan Pharmaceuticals Limited’s shares have been registered for dematerialization at CDSC, paving the way for listing on NEPSE and commencement of trading shortly after listing.
Sopan Pharmaceuticals Limited’s issued shares are now set to be converted into dematerialized form following an agreement with CDS and Clearing Limited (CDSC) on Jestha 8.
With this agreement, the company’s physical shares will be credited directly to investors’ demat accounts. After dematerialization, the shares will be listed on the Nepal Stock Exchange (NEPSE), and trading will begin from the next day of listing.
Earlier, the company had issued an IPO of 3,474,900 units to the general public between Baisakh 3 and Baisakh 8. The allotment of the IPO was completed on Baisakh 17.
The Securities Board of Nepal (SEBON) had granted approval for the IPO issuance on Falgun 17.
Once listed on NEPSE, Sopan Pharmaceuticals shares are expected to become available for trading, allowing investors to buy and sell through the secondary market.